Objectives
To compare residents of assisted living facilities receiving hospice with people receiving hospice care at home.
Design
Electronic health record–based retrospective cohort study.
Setting
Nonprofit hospices in the Coalition of Hospices Organized to Investigate Comparative Effectiveness network.
Participants
Individuals admitted to hospice between January 1, 2008, and May 15, 2012 (N = 85,581; 7,451 (8.7%) assisted living facility, 78,130 (91.3%) home).
Measurements
Hospice length of stay, use of opioids for pain, and site of death.
Results
The assisted living population was more likely than the home hospice population to have a diagnosis of dementia (23.5% vs 4.7%; odds ratio (OR) = 13.3, 95% confidence interval (CI) = 12.3–14.4; P < .001) and enroll in hospice closer to death (median length of stay 24 vs 29 days). Assisted living residents were less likely to receive opioids for pain (18.1% vs 39.7%; OR = 0.33, 95% CI = 0.29–0.39, P < .001) and less likely to die in an inpatient hospice unit (9.3% vs 16.1%; OR = 0.53, 95% CI = 0.49–0.58, P < .001) or a hospital (1.3% vs 7.6%; OR = 0.16, 95% CI = 0.13–0.19, P < .001).
Conclusion
Three are several differences between residents of assisted living receiving hospice care and individuals living at home receiving hospice care. A better understanding of these differences could allow hospices to develop guidelines for better coordination of end‐of‐life care for the assisted living population.